Acrivon Therapeutics Investor Relations Material
Latest events
R&D Update
Acrivon Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Acrivon Therapeutics Inc
Access all reports
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing precision oncology medicines. Utilizing its proprietary Acrivon Predictive Precision Proteomics (AP3) platform, the company advances drug candidates tailored to the predicted sensitivity of tumors to specific medicines. The company is headquartered in Watertown, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Acrivon Therapeutics Inc
R&D Update
Acrivon Therapeutics Inc
R&D Update
Acrivon Therapeutics Inc
Latest articles
Amazon's Most Notable Acquisitions Since Inception
Explore Amazon's most impactful acquisitions, from IMDb and Zappos to Whole Foods and MGM, and how these have diversified its business.
13 May 2024
Adidas vs Puma: The Story of the Dassler Brothers
An in-depth article outlining the story of the Dassler brothers, their feud with one another, and the history of Puma and Adidas.
10 May 2024
Satya Nadella: The Architect of Microsoft's Resurgence
The journey of Satya Nadella, from his early life in India to reshaping Microsoft as its CEO, emphasizing cloud computing and inclusive leadership.
10 May 2024
Ticker symbol
Country
🇺🇸 United States